Target Healthcare REIT (LON:THRL) Hits New 12-Month High – What’s Next?

Shares of Target Healthcare REIT (LON:THRL) reached a new 52-week high during mid-day trading on Tuesday. The company traded as high as GBX 117 and last traded at GBX 116.40, with a volume of 31,890 shares trading hands. The stock had previously closed at GBX 116.40.

Analyst Ratings Changes

Separately, Jefferies Financial Group reiterated a “buy” rating and issued a GBX 124 target price on shares of Target Healthcare REIT in a research note on Thursday, October 15th. One research analyst has rated the stock with a Buy rating. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of GBX 124.

Target Healthcare REIT Stock Performance

The business’s 50 day simple moving average is GBX 112.30 and its 200-day simple moving average is GBX 107.86. The stock has a market capitalization of £724.54 million, a price-to-earnings ratio of 8.77, a price-to-earnings-growth ratio of 1.48 and a beta of 0.71.

Target Healthcare REIT (LON:THRL) last posted its earnings results on Wednesday, September 23rd. The company reported GBX 13.32 EPS for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. As a group, sell-side analysts expect that Target Healthcare REIT will post 6.22 EPS for the current year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.